HPV vaccination programme in Japan

The Lancet

Volumn 382, Issue 9894, 2013, Pages 768-

  Gilmour, Stuart ^a   Kanda, Mikiko ^a   Kusumi, Eiji ^b   Tanimoto, Tetsuya ^b   Kami, Masahiro ^c   Shibuya, Kenji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Navitas Clinic   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

COMPLEX REGIONAL PAIN SYNDROME; HEALTH CARE FACILITY; HUMAN; JAPAN; LETTER; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH; VACCINATION;

EID: 84883134007     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61831-0     Document Type: Letter

References (3)

1. Yamamoto N, Mori R, Jacklin P, et al. Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: a cost-effectiveness analysis. BJOG 2012; 119: 177-86.
2. WHO. Causality assessment of adverse events following immunization. Wkly Epidemiol Rec 2001; 76: 85-89.
3. Centers for Disease Control and Prevention. Nationwide rubella epidemic - Japan, 2013. MMWR Morb Mortal Wkly Rep 2013; 62: 457-62.